This inventor holds 1 USPTO granted patent. Top assignee: A. Nattermann & Cie Gmbh. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Joachim Roeding: Innovator in Pharmaceutical Solutions
Introduction
Joachim Roeding is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on parenteral solutions.
Latest Patents
Roeding holds a patent for a "Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one." This invention relates to new parenteral preparations of 2-phenyl-1.2-benzisoselenazol-3(2H)-one (Ebselen), which includes one or several phospholipids and possibly additional auxiliary agents. The patent also covers the process for producing such solutions and their application in drug preparations of Ebselen.
Career Highlights
Roeding is associated with A. Nattermann & Cie GmbH, where he has been instrumental in advancing pharmaceutical innovations. His work has focused on enhancing the stability and efficacy of parenteral solutions, contributing to improved therapeutic options.
Collaborations
Throughout his career, Roeding has collaborated with colleagues such as Joerg Hager and Andrea M Huether. These partnerships have fostered a collaborative environment that encourages innovation and the development of new pharmaceutical solutions.
Conclusion
Joachim Roeding's contributions to the field of pharmaceuticals, particularly through his patent on stable parenteral solutions, highlight his role as an innovator. His work continues to impact the development of effective drug preparations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile